SCHEMBL4400284

SCHEMBL4400284

Cc1ccc(-c2cnc(-c3cc(-c4ccccc4)c(-c4ccc(C)cc4)cn3)cc2-c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.49
▸ HPGD P15428 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ PPARG P37231 2/20 0.47
▸ POLB P06746 2/20 0.47
▸ MCL1 Q07820 1/20 0.47
▸ NR2E3 Q9Y5X4 1/20 0.47
▸ NCOR2 Q9Y618 1/20 0.47
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ SENP8 Q96LD8 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46
▸ SENP6 Q9GZR1 1/20 0.46
▸ NCOA2 Q15596 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13962526 0.92 ADORA1 (0.52) KDM4EHPGDMEN1KMT2ATDP1
SCHEMBL4404649 0.85 ADORA1 (0.56) HPGDKMT2AMAPTALDH1A1L3MBTL1
SCHEMBL19454861 0.84 LDHA (0.57) KDM4EHPGDMEN1KMT2ATDP1
SCHEMBL21468869 0.81 KDM4E (0.50) KDM4EHPGDMEN1KMT2ATDP1
SCHEMBL9974926 0.81 CYP3A4 (0.54) KDM4EHPGDMEN1KMT2ATDP1
SCHEMBL5653453 0.81 NPC1 (0.50) KDM4ENPC1RAB9ASMN1; SMN2LDHA
SCHEMBL16285505 0.80 TSHR (0.43) KDM4EHPGDMEN1KMT2ATDP1
SCHEMBL17055512 0.79 MEN1 (0.55) KDM4EHPGDMEN1KMT2ATDP1
SCHEMBL4402518 0.78 ADORA1 (0.53) HPGDKMT2ANPC1RAB9AADORA2A
SCHEMBL10205838 0.78 CYP1A2 (0.48) KDM4EHPGDMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8877355-B2 Monoamine compound, charge-transporting material, and organic electroluminescent device MITSUBISHI CHEMICAL CORPORATION (JP) 2014-11-04 — — US disclosed
US-20130214263-A1 MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE MITSUBISHI CHEMICAL CORPORATION (JP) 2013-08-22 — — US disclosed
US-8427046-B2 Monoamine compound, charge-transporting material, and organic electroluminescent device MITSUBISHI CHEMICAL CORPORATION (JP) 2013-04-23 — — US disclosed
US-8168307-B2 Organic compound, charge transport material and organic electroluminescent device PIONEER CORPORATION (JP) 2012-05-01 — — US disclosed
US-20090230846-A1 MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE MITSUBISHI CHEMICAL CORPORATION (JP) 2009-09-17 — — US disclosed
US-20090021146-A1 ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE PIONEER CORPORATION (JP) 2009-01-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090021146-A1 ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE SLC25A21, SLCO2A1, OCIAD2 KDM4E 2880/4885HPGD 2889/4885MEN1 1827/4885
US-20090230846-A1 MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE SLC7A5, SLC18A1, MAOA KDM4E 1259/4885HPGD 1845/4885MEN1 2206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback